Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|January 2, 2001
Triamterene measurements in the aqueous humor of rabbitsO Hamid, A A Tajuddin
Drugs of Today (Barcelona, Spain : 1998)|June 30, 2012
Ipilimumab for metastatic melanomaJ Ozao-Choy, R D Carvajal, O Hamid
Journal of Biological Physics|January 25, 2013
Steady flow visualization in a rigid model of the aortic bifurcation: application to atherosclerosisQ M Ramadan, O Hamid, K O Lim
The Malaysian Journal of Medical Sciences : MJMS|September 13, 2012
Preliminary studies of left ventricular wall thickness and mass of normotensive and hypertensive subjects using m-mode echocardiographyM S Jaafar, O Hamid, C S Khor, et al.
Cureus|December 15, 2025
Disseminated Methicillin-Resistant Staphylococcus aureus (MRSA) Infection Masquerading as Community-Acquired MeningitisMohammed O Hamid, Hashim Ba Wazir, Fatma Salem Alhashemi Alsadi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 4, 2013
Phase II study of pemetrexed in combination with cisplatin and cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neckJ B Vermorken, L Licitra, J Stöhlmacher-Williams, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2014
Survival follow-up and ipilimumab retreatment of patients with advanced melanoma who received ipilimumab in prior phase II studiesC Lebbé, J S Weber, M Maio, et al.
Leukemia Research|July 20, 2018
Phase 2 study of gandotinib (LY2784544) in patients with myeloproliferative neoplasmsJ Berdeja, F Palandri, M R Baer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 29, 2013
Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II studyS F Slovin, C S Higano, O Hamid, et al.
Nature Communications|February 16, 2026
LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trialO Hamid, V Ekström-Rydén, I Mehmi, et al.
Pageof 2